Papers associated with tat

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Human-derived fusogenic peptides for the intracellular delivery of proteins., Sudo K, Niikura K, Iwaki K, Kohyama S, Fujiwara K, Doi N., J Control Release. June 10, 2017; 255 1-11.
	Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors., Qvit N, Schechtman D, Pena DA, Berti DA, Soares CO, Miao Q, Liang LA, Baron LA, Teh-Poot C, Martínez-Vega P, Ramirez-Sierra MJ, Churchill E, Cunningham AD, Malkovskiy AV, Federspiel NA, Gozzo FC, Torrecilhas AC, Manso Alves MJ, Jardim A, Momar N, Dumonteil E, Mochly-Rosen D., Int J Parasitol Drugs Drug Resist. February 12, 2016; 6 (1): 74-84.
	A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells., Lou H, Gao Y, Zhai M, Qi Y, Chen L, Lv H, Yu J, Li Y., Bioorg Med Chem Lett. August 15, 2008; 18 (16): 4633-7.
	Sequence specificity of DNA cleavage by bis(1,10-phenanthroline)copper(I)., Veal JM, Rill RL., Biochemistry. March 22, 1988; 27 (6): 1822-7.
	A model for the effects of potential and external K+ concentration on the Cs+ blocking of inward rectification., Ciani S, Krasne S, Hagiwara S., Biophys J. April 1, 1980; 30 (1): 199-204.

???pagination.result.page??? 1